Clinical Trial Update: Phase II Study of Clofarabine in Pediatric Acute Lymphoblastic Leukemia (ALL) [Phase 2]

View source ↗

Summary

Phase II study of clofarabine in pediatric acute lymphoblastic leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Leukemia Lymphoblastic Acute Pediatric

Drugs mentioned

• Clofarabine (clofarabine)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Leukemia, Lymphoblastic, Acute, Pediatric | Phase 2 | Status: COMPLETED